{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:54:08Z","timestamp":1787032448204,"version":"build-2736575974"},"reference-count":25,"publisher":"e-Century Publishing Corporation","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/aeek4110","type":"journal-article","created":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:05:06Z","timestamp":1759039506000},"page":"7067-7075","source":"Crossref","is-referenced-by-count":1,"title":["Transcutaneous tibial nerve stimulation combined mirabegron therapy significantly improves benign prostatic hyperplasia and overactive bladder: a prospective randomized controlled trial"],"prefix":"10.62347","volume":"17","author":[{"given":"Si-Cong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.medcli.2024.04.014","article-title":"Benign prostatic hyperplasia","volume":"163","author":"Hern&#xE1","year":"2024","unstructured":"Infante Hernández S, Gómez Rivas J and Moreno Sierra J. Benign prostatic hyperplasia. Med Clin (Barc) 2024; 163: 407-414.","journal-title":"Med Clin (Barc)"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Foo KT. What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)? World J Urol 2019; 37: 1293-1296.","DOI":"10.1007\/s00345-019-02691-0"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2478875","DOI":"10.1080\/13685538.2025.2478875","article-title":"National prevalence and incidence of benign prostatic hyperplasia\/lower urinary tract symptoms and validated risk factors pattern","volume":"28","author":"Lin","year":"2025","unstructured":"Lin L, Wang W, Shao Y, Li X and Zhou L. National prevalence and incidence of benign prostatic hyperplasia\/lower urinary tract symptoms and validated risk factors pattern. Aging Male 2025; 28: 2478875.","journal-title":"Aging Male"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/biomedicines12010110","article-title":"Evaluating the impact of benign prostatic hyperplasia surgical treatments on sexual health","volume":"12","author":"Kaltsas","year":"2024","unstructured":"Kaltsas A, Kratiras Z, Zachariou A, Dimitriadis F, Sofikitis N and Chrisofos M. Evaluating the impact of benign prostatic hyperplasia surgical treatments on sexual health. Biomedicines 2024; 12: 110.","journal-title":"Biomedicines"},{"key":"ref4","unstructured":"Ng M, Leslie SW and Baradhi KM. Benign prostatic hyperplasia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; October 20, 2024."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/00325481.2015.1018799","article-title":"Benign prostatic hyperplasia and urinary symptoms: evaluation and treatment","volume":"127","author":"Mobley","year":"2015","unstructured":"Mobley D, Feibus A and Baum N. Benign prostatic hyperplasia and urinary symptoms: evaluation and treatment. Postgrad Med 2015; 127: 301-307.","journal-title":"Postgrad Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"16031","DOI":"10.1038\/nrdp.2016.31","article-title":"Benign prostatic hyperplasia","volume":"2","author":"Chughtai","year":"2016","unstructured":"Chughtai B, Forde JC, Thomas DD, Laor L, Hossack T, Woo HH, Te AE and Kaplan SA. Benign prostatic hyperplasia. Nat Rev Dis Primers 2016; 2: 16031.","journal-title":"Nat Rev Dis Primers"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/pros.24656","article-title":"Link between circadian rhythm and benign prostatic hyperplasia (BPH)\/lower urinary tract symptoms (LUTS)","volume":"84","author":"Cavanaugh","year":"2024","unstructured":"Cavanaugh D, Urbanucci A, Mohamed NE, Tewari AK, Figueiro M and Kyprianou N. Link between circadian rhythm and benign prostatic hyperplasia (BPH)\/lower urinary tract symptoms (LUTS). Prostate 2024; 84: 417-425.","journal-title":"Prostate"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.aju.2018.06.007","article-title":"Oral desmopressin in nocturia with benign prostatic hyperplasia: a systematic review of the literature","volume":"16","author":"DE","year":"2018","unstructured":"Taha DE, Aboumarzouk OM and Shokeir AA. Oral desmopressin in nocturia with benign prostatic hyperplasia: a systematic review of the literature. Arab J Urol 2018; 16: 404-410.","journal-title":"Arab J Urol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s41999-023-00798-7","article-title":"Management of use of urinary antimuscarinics and alpha blockers for benign prostatic hyperplasia in older adults at risk of falls: a clinical review","volume":"14","author":"&#x130","year":"2023","unstructured":"İlhan B, Erdoğan T, Topinková E and Bahat G; EuGMS Task and Finish Group on FRIDs. Management of use of urinary antimuscarinics and alpha blockers for benign prostatic hyperplasia in older adults at risk of falls: a clinical review. Eur Geriatr Med 2023; 14: 733-746.","journal-title":"Eur Geriatr Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"6014","DOI":"10.3390\/ijms22116014","article-title":"Bladder hyperactivity induced by oxidative stress and bladder ischemia: a review of treatment strategies with antioxidants","volume":"22","author":"YH","year":"2021","unstructured":"Wu YH, Chueh KS, Chuang SM, Long CY, Lu JH and Juan YS. Bladder hyperactivity induced by oxidative stress and bladder ischemia: a review of treatment strategies with antioxidants. Int J Mol Sci 2021; 22: 6014.","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"11116","DOI":"10.1038\/s41598-024-61977-5","article-title":"Comparative efficacy and safety of alpha-blockers as monotherapy for benign prostatic hyperplasia: a systematic review and network meta-analysis","volume":"14","author":"Yoosuf","year":"2024","unstructured":"Yoosuf BT, Panda AK, Kt MF, Bharti SK, Devana SK and Bansal D. Comparative efficacy and safety of alpha-blockers as monotherapy for benign prostatic hyperplasia: a systematic review and network meta-analysis. Sci Rep 2024; 14: 11116.","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11934-023-01165-6","article-title":"Role of bladder functional testing prior to surgeries for benign prostatic obstruction","volume":"24","author":"Mazeaud","year":"2023","unstructured":"Mazeaud C, Hernandez N and Gonzalez RR. Role of bladder functional testing prior to surgeries for benign prostatic obstruction. Curr Urol Rep 2023; 24: 401-407.","journal-title":"Curr Urol Rep"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.neurom.2022.04.034","article-title":"Transcutaneous tibial nerve stimulation in the management of overactive bladder: a scoping review","volume":"25","author":"Sayner","year":"2022","unstructured":"Sayner AM, Rogers F, Tran J, Jovanovic E, Henningham L and Nahon I. Transcutaneous tibial nerve stimulation in the management of overactive bladder: a scoping review. Neuromodulation 2022; 25: 1086-1096.","journal-title":"Neuromodulation"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/nau.23351","article-title":"The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: a systematic review","volume":"37","author":"Booth","year":"2018","unstructured":"Booth J, Connelly L, Dickson S, Duncan F and Lawrence M. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: a systematic review. Neurourol Urodyn 2018; 37: 528-541.","journal-title":"Neurourol Urodyn"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/ajo.13822","article-title":"Percutaneous tibial nerve stimulation for the overactive bladder: a single-arm trial","volume":"64","author":"HY","year":"2024","unstructured":"Kyaw HY, Krause HG and Goh JTW. Percutaneous tibial nerve stimulation for the overactive bladder: a single-arm trial. Aust N Z J Obstet Gynaecol 2024; 64: 501-505.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/j.juro.2010.06.113","article-title":"Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial","volume":"184","author":"Finazzi-Agr&#xF2","year":"2010","unstructured":"Finazzi-Agrò E, Petta F, Sciobica F, Pasqualetti P, Musco S and Bove P. Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial. J Urol 2010; 184: 2001-2006.","journal-title":"J Urol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1590\/s1677-5538.ibju.2016.0611","article-title":"Effectiveness and durability of solifenacin versus percutaneous tibial nerve stimulation versus their combination for the treatment of women with overactive bladder syndrome: a randomized controlled study with a follow-up of ten months","volume":"44","author":"Vecchioli-Scaldazza","year":"2018","unstructured":"Vecchioli-Scaldazza C and Morosetti C. Effectiveness and durability of solifenacin versus percutaneous tibial nerve stimulation versus their combination for the treatment of women with overactive bladder syndrome: a randomized controlled study with a follow-up of ten months. Int Braz J Urol 2018; 44: 102-108.","journal-title":"Int Braz J Urol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/bju.16330","article-title":"Efficacy and safety of tibial nerve stimulation using a wearable device for overactive bladder","volume":"133","author":"Liao","year":"2024","unstructured":"Liao L, Li X and Chong T. Efficacy and safety of tibial nerve stimulation using a wearable device for overactive bladder. BJU Int 2024; 133: 760-769.","journal-title":"BJU Int"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"27248","DOI":"10.1038\/s41598-024-78492-2","article-title":"Efficacy of the combination of transcutaneous tibial nerve stimulation and mirabegron in women with overactive bladder in a prospective randomized controlled trial","volume":"14","author":"YX","year":"2024","unstructured":"Xu YX, Xiong Y, Tian HQ, Yang YH, Tao RZ and Li YP. Efficacy of the combination of transcutaneous tibial nerve stimulation and mirabegron in women with overactive bladder in a prospective randomized controlled trial. Sci Rep 2024; 14: 27248.","journal-title":"Sci Rep"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00345-024-05084-0","article-title":"Efficacy of transcutaneous electrical nerve stimulation combined with mirabegron therapy compared with mirabegron monotherapy for overactive bladder: a prospective randomized controlled study","volume":"42","author":"Zhao","year":"2024","unstructured":"Zhao L, Wu F, Wang J, Wang Y, Peng W and Chen Y. Efficacy of transcutaneous electrical nerve stimulation combined with mirabegron therapy compared with mirabegron monotherapy for overactive bladder: a prospective randomized controlled study. World J Urol 2024; 42: 370.","journal-title":"World J Urol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00192-024-05835-y","article-title":"Posterior Tibial nerve stimulation with versus without mirabegron: a randomized controlled trial","volume":"35","author":"Stanley","year":"2024","unstructured":"Stanley RF, Meyer I, Blanchard CT and Richter HE. Posterior Tibial nerve stimulation with versus without mirabegron: a randomized controlled trial. Int Urogynecol J 2024; 35: 1709-1717.","journal-title":"Int Urogynecol J"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neurom.2023.03.017","article-title":"Mechanism of action of Tibial nerve stimulation in the treatment of lower urinary tract dysfunction","volume":"27","author":"Li","year":"2024","unstructured":"Li X, Li X and Liao L. Mechanism of action of Tibial nerve stimulation in the treatment of lower urinary tract dysfunction. Neuromodulation 2024; 27: 256-266.","journal-title":"Neuromodulation"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00192-023-05704-0","article-title":"Effects of transcutaneous tibial nerve stimulation in women refractory to and never used pharmacological agents for idiopathic overactive bladder","volume":"35","author":"Yildiz","year":"2024","unstructured":"Yildiz N and Celtek MA. Effects of transcutaneous tibial nerve stimulation in women refractory to and never used pharmacological agents for idiopathic overactive bladder. Int Urogynecol J 2024; 35: 571-578.","journal-title":"Int Urogynecol J"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s11255-022-03235-z","article-title":"Home-based transcutaneous tibial nerve stimulation for overactive bladder syndrome: a randomized, controlled study","volume":"54","author":"Cava","year":"2022","unstructured":"Cava R and Orlin Y. Home-based transcutaneous tibial nerve stimulation for overactive bladder syndrome: a randomized, controlled study. Int Urol Nephrol 2022; 54: 1825-1835.","journal-title":"Int Urol Nephrol"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/9\/ajtr0167068.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T03:08:58Z","timestamp":1769051338000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/9\/ajtr0167068.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/aeek4110","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}